Found: 309
Select item for more details and to access through your institution.
Repeatability of vibration‐controlled transient elastography versus magnetic resonance elastography in patients with cirrhosis: A prospective study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 4, p. 484, doi. 10.1111/apt.18118
- By:
- Publication type:
- Article
The impact of genetic risk on the prevalence of advanced fibrosis and cirrhosis in prospectively assessed patients with type 2 diabetes.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 3, p. 369, doi. 10.1111/apt.18099
- By:
- Publication type:
- Article
Integrating genetic and socioeconomic data to predict the progression of nonalcoholic fatty liver disease.
- Published in:
- American Journal of Biological Anthropology, 2024, v. 184, n. 4, p. 1, doi. 10.1002/ajpa.24979
- By:
- Publication type:
- Article
Association of Immediate Postoperative Hemodynamic and Laboratory Values in Predicting Norwood Admission Outcomes.
- Published in:
- Pediatric Cardiology, 2024, v. 45, n. 6, p. 1232, doi. 10.1007/s00246-022-03044-2
- By:
- Publication type:
- Article
Hocus POCUS! Parental Quantification of Left-Ventricular Ejection Fraction Using Point of Care Ultrasound: Fiction or Reality?
- Published in:
- Pediatric Cardiology, 2024, v. 45, n. 6, p. 1289, doi. 10.1007/s00246-022-03090-w
- By:
- Publication type:
- Article
Acute Effects of Sacubitril/Valsartan with Initial Initiation in Pediatric Patients in the Cardiac Intensive Care Unit.
- Published in:
- Pediatric Cardiology, 2024, v. 45, n. 6, p. 1359, doi. 10.1007/s00246-023-03138-5
- By:
- Publication type:
- Article
Randomised clinical trial: Design of the SYNERGY‐NASH phase 2b trial to evaluate tirzepatide as a treatment for metabolic dysfunction‐associated steatohepatitis and modification of screening strategy to reduce screen failures.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 1, p. 17, doi. 10.1111/apt.18042
- By:
- Publication type:
- Article
Long‐term clinical outcomes in steatotic liver disease and incidence of liver‐related events, cardiovascular events and all‐cause mortality.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 1, p. 61, doi. 10.1111/apt.18015
- By:
- Publication type:
- Article
Editorial: Has MetALD met the presumption? Authors' reply.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
An Electronic Health Record Model for Predicting Risk of Hepatic Fibrosis in Primary Care Patients.
- Published in:
- Digestive Diseases & Sciences, 2024, v. 69, n. 7, p. 2430, doi. 10.1007/s10620-024-08437-2
- By:
- Publication type:
- Article
More Data Needed on GLP-1s, Dual Agonists to Reach 'Optimal' Management of MASH, Diabetes.
- Published in:
- Healio Gastroenterology, 2024, v. 10, n. 7, p. 20
- By:
- Publication type:
- Article
Natural history of clinical outcomes and hepatic decompensation in metabolic dysfunction‐associated steatotic liver disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 12, p. 1521, doi. 10.1111/apt.17981
- By:
- Publication type:
- Article
A prospective study on the prevalence of at‐risk MASH in patients with type 2 diabetes mellitus in the United States.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 12, p. 1571, doi. 10.1111/apt.17997
- By:
- Publication type:
- Article
Monitoring disease progression in metabolic dysfunction‐associated steatotic liver disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 1, p. S41, doi. 10.1111/apt.17752
- By:
- Publication type:
- Article
A combination of non-invasive tests for the detection of significant fibrosis in patients with metabolic dysfunction-associated steatotic liver disease is not superior to magnetic resonance elastography alone.
- Published in:
- European Radiology, 2024, v. 34, n. 6, p. 3882, doi. 10.1007/s00330-023-10441-5
- By:
- Publication type:
- Article
Association between balloon atrial septostomy and prostaglandin E1 therapy until repair of transposition of the great arteries in neonates.
- Published in:
- Pediatric Investigation, 2024, v. 8, n. 2, p. 135, doi. 10.1002/ped4.12425
- By:
- Publication type:
- Article
Review article: New developments in biomarkers and clinical drug development in alpha‐1 antitrypsin deficiency‐related liver disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 10, p. 1183, doi. 10.1111/apt.17967
- By:
- Publication type:
- Article
Prevalence of at‐risk MASH, MetALD and alcohol‐associated steatotic liver disease in the general population.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 10, p. 1271, doi. 10.1111/apt.17958
- By:
- Publication type:
- Article
Editorial: Crystalising the burden of steatotic liver disease—Authors' reply.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Review article: Current indications and selection criteria for early liver transplantation in severe alcohol‐associated hepatitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 9, p. 1049, doi. 10.1111/apt.17948
- By:
- Publication type:
- Article
Potential Therapeutic Targets in Obesity, Sleep Apnea, Diabetes, and Fatty Liver Disease.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 8, p. 2231, doi. 10.3390/jcm13082231
- By:
- Publication type:
- Article
Correlation of hepatic venous saturation and mixed venous saturation: pooled analyses.
- Published in:
- Minerva Pediatrics, 2024, v. 76, n. 2, p. 253, doi. 10.23736/S2724-5276.23.07208-7
- By:
- Publication type:
- Article
Postoperative Atrioventricular Block in Pediatric Patients: Impact of Congenital Cardiac Malformations and Medications.
- Published in:
- Pediatric Cardiology, 2024, v. 45, n. 4, p. 759, doi. 10.1007/s00246-024-03427-7
- By:
- Publication type:
- Article
Pulmonary Atresia with Intact Ventricular Septum: Midterm Outcomes from a Multicenter Cohort.
- Published in:
- Pediatric Cardiology, 2024, v. 45, n. 4, p. 847, doi. 10.1007/s00246-022-02954-5
- By:
- Publication type:
- Article
Aspirin for Metabolic Dysfunction–Associated Steatotic Liver Disease Without Cirrhosis: A Randomized Clinical Trial.
- Published in:
- JAMA: Journal of the American Medical Association, 2024, v. 331, n. 11, p. 920, doi. 10.1001/jama.2024.1215
- By:
- Publication type:
- Article
Meta‐analysis: Prevalence and impact of alcohol abstinence in alcohol‐associated cirrhosis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 6, p. 730, doi. 10.1111/apt.17888
- By:
- Publication type:
- Article
Editorial: Updated epidemiology of steatotic liver disease in people with HIV in the United States—Authors' reply.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Prevalence of steatotic liver disease, MASLD, MetALD and significant fibrosis in people with HIV in the United States.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 5, p. 666, doi. 10.1111/apt.17849
- By:
- Publication type:
- Article
Echocardiographic measured shunt velocity does not predict pulmonary blood flow in patients with Blalock–Thomas–Taussig shunt.
- Published in:
- Cardiology in the Young, 2024, v. 34, n. 3, p. 535, doi. 10.1017/S104795112300269X
- By:
- Publication type:
- Article
Exercise training improves serum biomarkers of liver fibroinflammation in patients with metabolic dysfunction-associated steatohepatitis.
- Published in:
- Liver International, 2024, v. 44, n. 2, p. 534, doi. 10.1111/liv.15769
- By:
- Publication type:
- Article
Discovery of a peripheral 5HT<sub>2A</sub> antagonist as a clinical candidate for metabolic dysfunction-associated steatohepatitis.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-44874-3
- By:
- Publication type:
- Article
Implications of the new nomenclature of steatotic liver disease and definition of metabolic dysfunction‐associated steatotic liver disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 2, p. 150, doi. 10.1111/apt.17846
- By:
- Publication type:
- Article
Letter: Are we forgetting the importance of steatosis in steatotic liver disease? Authors' reply.
- Published in:
- 2024
- By:
- Publication type:
- Letter to the Editor
A Message from the Editors.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 1, p. 4, doi. 10.1111/apt.17797
- By:
- Publication type:
- Article
Design of the phase 3 MAESTRO clinical program to evaluate resmetirom for the treatment of nonalcoholic steatohepatitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 1, p. 51, doi. 10.1111/apt.17734
- By:
- Publication type:
- Article
Low liver fat in non‐alcoholic steatohepatitis‐related significant fibrosis and cirrhosis is associated with hepatocellular carcinoma, decompensation and mortality.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 1, p. 80, doi. 10.1111/apt.17783
- By:
- Publication type:
- Article
Reduced length of stay after implementation of a clinical pathway following repair of ventricular septal defect.
- Published in:
- Cardiology in the Young, 2024, v. 34, n. 1, p. 101, doi. 10.1017/S1047951123001245
- By:
- Publication type:
- Article
Association Between Congenital Heart Disease and Stroke: Insights from a National Database.
- Published in:
- Pediatric Cardiology, 2024, v. 45, n. 1, p. 1, doi. 10.1007/s00246-023-03315-6
- By:
- Publication type:
- Article
Predicting inpatient mortality in pediatric traumatic brain injury: insights from a national database.
- Published in:
- Child's Nervous System, 2023, v. 39, n. 12, p. 3521, doi. 10.1007/s00381-023-06010-2
- By:
- Publication type:
- Article
Clinical trial: Effects of pegozafermin on the liver and on metabolic comorbidities in subjects with biopsy‐confirmed nonalcoholic steatohepatitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 58, n. 10, p. 1005, doi. 10.1111/apt.17709
- By:
- Publication type:
- Article
The silent burden of non‐alcoholic fatty liver disease in the elderly: A global burden of disease analysis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 58, n. 10, p. 1062, doi. 10.1111/apt.17714
- By:
- Publication type:
- Article
Editorial: Can liver fat quantification stratify cardiovascular risk in type 2 diabetes? Authors' reply.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
MEFIB‐Index and MAST‐Score in the assessment of hepatic decompensation in metabolic dysfunction‐associated steatosis liver disease—Individual participant data meta‐analyses.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 58, n. 9, p. 856, doi. 10.1111/apt.17707
- By:
- Publication type:
- Article
Global Epidemiology of Cirrhosis: Changing Etiological Basis and Comparable Burden of Nonalcoholic Steatohepatitis between Males and Females.
- Published in:
- Digestive Diseases, 2023, v. 41, n. 6, p. 900, doi. 10.1159/000533946
- By:
- Publication type:
- Article
Haemodynamic and clinical variables after surgical systemic to pulmonary artery shunt placement versus arterial ductal stenting.
- Published in:
- Cardiology in the Young, 2023, v. 33, n. 10, p. 2060, doi. 10.1017/S104795112200395X
- By:
- Publication type:
- Article
The effect of clinical and haemodynamic variables on post-operative length of stay immediately upon admission after biventricular repair with Yasui operation following an earlier Norwood operation.
- Published in:
- Cardiology in the Young, 2023, v. 33, n. 10, p. 2066, doi. 10.1017/S1047951122003948
- By:
- Publication type:
- Article
Clinical utility of liver fat quantification for determining cardiovascular disease risk among patients with type 2 diabetes.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 58, n. 6, p. 585, doi. 10.1111/apt.17637
- By:
- Publication type:
- Article
Clinical parameters to predict adverse outcomes in patients with shunt-dependent physiology with a Blalock--Taussig--Thomas shunt.
- Published in:
- Annals of Pediatric Cardiology, 2023, v. 16, n. 5, p. 345, doi. 10.4103/apc.apc_135_23
- By:
- Publication type:
- Article
Quality Assessment of Ultrasound and Magnetic Resonance Imaging for Hepatocellular Carcinoma Surveillance: A Systematic Review and Meta-Analysis.
- Published in:
- Digestive Diseases, 2023, v. 41, n. 5, p. 757, doi. 10.1159/000531016
- By:
- Publication type:
- Article
Survival Trends in Sorafenib for Advanced Hepatocellular Carcinoma: A Reconstructed Individual Patient Data Meta-Analysis of Randomized Trials.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 5, p. 445, doi. 10.1159/000529824
- By:
- Publication type:
- Article